Research statistics
Pralmorelin (GHRP-2) research: publications and trials
At a glance
Publications, all years
202
Since 1993
Publications in 2026 so far
4
Through November 15, 2026
Human clinical research
45.0%
91 of 202 classified
Registered clinical trials
0
ClinicalTrials.gov
Randomized controlled trials
44
Publications reporting an RCT in people
Systematic reviews and meta-analyses
0
Preclinical studies
47.0%
68 animal · 27 in vitro · 0 computational
Records that only mention it
36
Not counted above
Status in the library: Research only. Groups: Growth hormone axis.
Publications by year
Pralmorelin (GHRP-2) publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 1993 | 0 | 0 | 1 | 0 | 1 |
| 1994 | 0 | 2 | 0 | 0 | 2 |
| 1995 | 3 | 3 | 0 | 0 | 6 |
| 1996 | 2 | 6 | 1 | 0 | 9 |
| 1997 | 5 | 5 | 1 | 0 | 11 |
| 1998 | 6 | 9 | 3 | 0 | 18 |
| 1999 | 5 | 2 | 0 | 0 | 7 |
| 2000 | 6 | 5 | 1 | 0 | 12 |
| 2001 | 4 | 4 | 1 | 0 | 9 |
| 2002 | 2 | 7 | 0 | 0 | 9 |
| 2003 | 1 | 2 | 0 | 0 | 3 |
| 2004 | 6 | 6 | 1 | 0 | 13 |
| 2005 | 4 | 7 | 0 | 0 | 11 |
| 2006 | 1 | 2 | 0 | 0 | 3 |
| 2007 | 5 | 2 | 0 | 0 | 7 |
| 2008 | 3 | 0 | 1 | 0 | 4 |
| 2009 | 8 | 6 | 0 | 0 | 14 |
| 2010 | 7 | 2 | 1 | 0 | 10 |
| 2011 | 3 | 4 | 1 | 0 | 8 |
| 2012 | 1 | 3 | 0 | 0 | 4 |
| 2013 | 2 | 2 | 0 | 0 | 4 |
| 2014 | 1 | 4 | 0 | 1 | 6 |
| 2015 | 2 | 3 | 0 | 0 | 5 |
| 2016 | 2 | 2 | 0 | 0 | 4 |
| 2017 | 2 | 0 | 0 | 0 | 2 |
| 2018 | 3 | 2 | 0 | 1 | 6 |
| 2019 | 1 | 1 | 0 | 0 | 2 |
| 2020 | 0 | 2 | 1 | 0 | 3 |
| 2022 | 2 | 0 | 0 | 0 | 2 |
| 2023 | 1 | 0 | 0 | 0 | 1 |
| 2024 | 1 | 1 | 0 | 0 | 2 |
| 2026 (to date) | 2 | 1 | 1 | 0 | 4 |
Study types
| Animal study | 68 |
|---|---|
| Randomized controlled trial | 44 |
| Other clinical trial | 30 |
| In vitro study | 27 |
| Review | 14 |
| Observational human study | 13 |
| Case report | 4 |
| Editorial, letter or other | 2 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Endocrinology | 133 |
|---|---|
| Neurological and mental health | 53 |
| Metabolic health | 32 |
| Longevity and aging | 24 |
| Obesity and weight management | 24 |
| Musculoskeletal | 12 |
| Reproductive and sexual health | 11 |
| Oncology | 10 |
| Cardiovascular | 8 |
| Tissue repair | 8 |
| Gastrointestinal | 6 |
| Immune system | 6 |
Registered clinical trials
A registration is not a result.
No registered trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation.
PloS one · February 19, 2016 · Randomized controlled trial · cited 29 times · open access
PMID 26894743 · DOI 10.1371/journal.pone.0149461 · Human clinical research
- Increased Secretion of Endogenous GH after Treatment with an Intranasal GH-releasing Peptide-2 Spray Does Not Promote Growth in Short Children with GH Deficiency.
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · October 1, 2014 · Randomized controlled trial · cited 5 times · open access
PMID 25374440 · DOI 10.1297/cpe.23.107 · Human clinical research
- Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.
European journal of endocrinology · November 29, 2013 · Randomized controlled trial · cited 15 times · open access
PMID 24114435 · DOI 10.1530/eje-13-0733 · Human clinical research
- Differential pulsatile secretagogue control of GH secretion in healthy men.
American journal of physiology. Regulatory, integrative and comparative physiology · March 13, 2013 · Randomized controlled trial · cited 5 times · open access
PMID 23485864 · DOI 10.1152/ajpregu.00069.2013 · Human clinical research
- Regulated recovery of pulsatile growth hormone secretion from negative feedback: a preclinical investigation.
American journal of physiology. Regulatory, integrative and comparative physiology · July 27, 2011 · Randomized controlled trial · cited 4 times · open access
PMID 21795635 · DOI 10.1152/ajpregu.00293.2011 · Human clinical research
- Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men.
The Journal of clinical endocrinology and metabolism · May 25, 2011 · Randomized controlled trial · cited 11 times · open access
PMID 21613353 · DOI 10.1210/jc.2011-0298 · Human clinical research
- Complex regulation of GH autofeedback under dual-peptide drive: studies under a pharmacological GH and sex steroid clamp.
American journal of physiology. Endocrinology and metabolism · April 5, 2011 · Randomized controlled trial · cited 8 times · open access
PMID 21467302 · DOI 10.1152/ajpendo.00054.2011 · Human clinical research
- Secretagogue type, sex-steroid milieu, and abdominal visceral adiposity individually determine secretagogue-stimulated cortisol secretion.
European journal of endocrinology · March 18, 2010 · Randomized controlled trial · cited 2 times · open access
PMID 20299490 · DOI 10.1530/eje-10-0149 · Human clinical research
- Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.
The Journal of clinical endocrinology and metabolism · October 26, 2009 · Randomized controlled trial · cited 18 times · open access
PMID 19858315 · DOI 10.1210/jc.2009-1769 · Human clinical research
- Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women.
American journal of physiology. Endocrinology and metabolism · May 26, 2009 · Randomized controlled trial · cited 18 times · open access
PMID 19470834 · DOI 10.1152/ajpendo.00230.2009 · Human clinical research
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness.
The Journal of clinical endocrinology and metabolism · April 1, 1999 · Randomized controlled trial · cited 233 times
PMID 10199772 · DOI 10.1210/jcem.84.4.5636 · Human clinical research
- Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues.
The Journal of clinical endocrinology and metabolism · February 1, 1998 · Randomized controlled trial · cited 204 times
PMID 9467533 · DOI 10.1210/jcem.83.2.4575 · Human clinical research
- GH releasing peptides--structure and kinetics.
The Journal of pediatric endocrinology · January 1, 1993 · Review · cited 181 times
PMID 8374685 · DOI 10.1515/jpem.1993.6.1.21 · Reviews and meta-analyses
- Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.
American journal of physiology. Endocrinology and metabolism · October 26, 2004 · Animal study · cited 172 times · open access
PMID 15507538 · DOI 10.1152/ajpendo.00196.2004 · Animal studies
- Growth hormone-releasing peptides.
European journal of endocrinology · May 1, 1997 · Review · cited 168 times
PMID 9186261 · DOI 10.1530/eje.0.1360445 · Reviews and meta-analyses
Latest publications
- Differentiating hypothalamic from pituitary adrenal insufficiency: underlying causes and diagnostic utility of the corticotropin-releasing hormone and growth hormone-releasing peptide-2 stimulation tests.
Endocrine journal · September 11, 2026 · Observational human study · cited 0 times · open access
PMID 42732957 · DOI 10.1507/endocrj.ej26-0192 · Human clinical research
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.
Frontiers in endocrinology · June 18, 2026 · Review · cited 1 times · open access
PMID 42395176 · DOI 10.3389/fendo.2026.1822475 · Reviews and meta-analyses
- Possible Involvement of Hypothalamic Dysfunction in Long COVID Patients Characterized by Delayed Response to Gonadotropin-Releasing Hormone.
International journal of molecular sciences · January 14, 2026 · Observational human study · cited 1 times · open access
PMID 41596479 · DOI 10.3390/ijms27020832 · Human clinical research
- Diurnal and Daily Variations in Growth Hormone and Growth Hormone Stimulation Test in Male Cynomolgus Monkeys.
In vivo (Athens, Greece) · January 1, 2026 · Animal study · cited 0 times · open access
PMID 41482410 · DOI 10.21873/invivo.14182 · Animal studies
- Growth Hormone-Releasing Peptide 2 May Be Associated With Decreased M1 Macrophage Production and Increased Histologic and Biomechanical Tendon-Bone Healing Properties in a Rat Rotator Cuff Tear Model.
Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association · December 12, 2024 · Animal study · cited 8 times
PMID 39672241 · DOI 10.1016/j.arthro.2024.11.094 · Animal studies
- Robust growth hormone responses to GH-releasing peptide 2 in adolescents.
Journal of pediatric endocrinology & metabolism : JPEM · July 4, 2024 · Observational human study · cited 0 times
PMID 38958228 · DOI 10.1515/jpem-2024-0115 · Human clinical research
- Assessment of anterior pituitary reserve capacity based on growth hormone response to growth hormone-releasing peptide-2 test in the elderly.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · June 2, 2023 · Observational human study · cited 0 times · open access
PMID 37295337 · DOI 10.1016/j.ghir.2023.101545 · Human clinical research
- Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder.
Journal of the Endocrine Society · June 6, 2022 · Other clinical trial · cited 7 times · open access
PMID 35795807 · DOI 10.1210/jendso/bvac088 · Human clinical research
- Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors.
PloS one · April 22, 2022 · Observational human study · cited 3 times · open access
PMID 35452483 · DOI 10.1371/journal.pone.0267324 · Human clinical research
- On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse.
Drug testing and analysis · November 25, 2020 · In vitro study · cited 16 times
PMID 33197153 · DOI 10.1002/dta.2975 · In vitro studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: GHRP-2; GPA 748; KP-102; Pralmorelin
((TITLE_ABS:"GHRP-2" OR CHEM:"GHRP-2" OR TITLE_ABS:"GHRP2" OR CHEM:"GHRP2") OR (TITLE_ABS:"GPA 748" OR CHEM:"GPA 748" OR TITLE_ABS:"GPA748" OR CHEM:"GPA748") OR (TITLE_ABS:"KP-102" OR CHEM:"KP-102" OR TITLE_ABS:"KP102" OR CHEM:"KP102") OR (TITLE_ABS:"Pralmorelin" OR CHEM:"Pralmorelin")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Pralmorelin (GHRP-2) research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/pralmorelin-ghrp2